Metraipolis › archive › dc_88fe19403adf

Virologic, Lipid, Renal and Hepatic Laboratory Outcomes After Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Treatment-Experienced People… — Europe PMC PMID:42776656

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42776656
DOI
10.3390/idr18050105
License (as archived)
solo-consultazione
Archived
2026-10-08T03:25:07.345Z
SHA-256 of the archived text
5f3d33c588aefc188f6109fe8a22e2f99174ba5b5852f5a978897aad06fd5f75
Stable URL of this page
https://metraipolis.com/documento/dc_88fe19403adf

How to cite

Virologic, Lipid, Renal and Hepatic Laboratory Outcomes After Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Treatment-Experienced People… — Europe PMC PMID:42776656 — Europe PMC (en), https://europepmc.org/article/MED/42776656 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_88fe19403adf (Metraipolis archive dc_88fe19403adf, sha256 5f3d33c588aefc188f6109fe8a22e2f99174ba5b5852f5a978897aad06fd5f75)
BibTeX
@misc{dc88fe19403adf,
  title = {Virologic, Lipid, Renal and Hepatic Laboratory Outcomes After Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Treatment-Experienced People… — Europe PMC PMID:42776656},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42776656},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_88fe19403adf; sha256 5f3d33c588aefc188f6109fe8a22e2f99174ba5b5852f5a978897aad06fd5f75},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42776656. Agents can read the archived copy with the MCP tool read_document.